RecruitingNCT07406945
Safety and outcomes of SpydrBlade Flex during endoscopic achalasia treatment
About this title
Read the official source — NCT07406945Device studyAges 18+Ecuador + ChinaBipolarity
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- Guayaquil and 1 more locationSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: November 1, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 73
- Sponsor
- Chinese University of Hong Kong
- Sponsor type
- University
- Study type
- Device
- Intervention type
- Device
- Locations
- Ecuador, China
- Age range
- Over 18 Years
- Official registry ID
- NCT07406945
- Official title
Show the full official title
Safety and Efficacy of the Novel SpydrBlade Flex With Radiofrequency and Microwave Ablation Flexible Bipolar for Per-Oral Endoscopic Myotomy in Patients With Achalasia: A Multicenter Prospective Study
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Guayaquil, Ecuador · Hong Kong, Hong Kong · China
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Chinese University of Hong Kong, a university.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as recruiting.
